Skip to content

Clinical trials

Completed Phase 3 Disease Progression trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disease Progression Phase: Phase 3 Status: Completed Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20061
20103
20151
20161
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)2
AGO Study Group1
AVEO Pharmaceuticals, Inc.1
Barts & The London NHS Trust1
Boehringer Ingelheim1
Harvard School of Public Health (HSPH)1
Heidelberg University1
Kyorin University1
National Institute of Allergy and Infectious Diseases (NIAID)1
UNICEF1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disease Progression13
HIV Infections3
Acquired Immunodeficiency Syndrome2
Hematologic Diseases2
Multiple Myeloma2
Recurrence2
Anemia, Iron-Deficiency1
COVID-191
Carcinoma, Renal Cell1
Cardiovascular Diseases1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.